Anteris Announces Upcoming EMBARK Study Data Presentation at TCT 2026
Anteris says Azeem Latib will present the first 30-day clinical and hemodynamic outcomes for its medium-size DurAVR transcatheter valve at TCT 2026.
Related stories
Intercontinental Exchange shares rise 5.8%, on pace for best day since 2020
ICE shares were up 5.8% Thursday, their largest percentage gain since March 2020, according to Dow Jones Market Data.
M impact | EQUITY | Oct 29, 2026, 05:44 PM UTC
Teck Resources Keeps Quarterly Dividend at CA$0.125 a Share
The quarterly dividend is payable Dec. 31 to shareholders of record on Dec. 15.
M impact | EQUITY | Oct 29, 2026, 05:44 PM UTC
UCAR: trading halted on Nasdaq — volatility pause (1:42 PM ET)
Nasdaq halted trading in UCAR (volatility pause) at 1:42 PM ET.
L impact | EQUITY | Oct 29, 2026, 05:43 PM UTC
Shell Raises Buyback Commitment to $5 Billion
Shell raised its repurchase commitment to $5 billion over approximately three months. Its U.S. depositary shares rose 2.41% to $107.72 at 11:55 a.m. ET on October 29.
M impact | EQUITY | Oct 29, 2026, 05:41 PM UTC
Chipotle Shares Rise 8.44% as Customer Traffic Improves
Chipotle shares rose 8.44% to $31.155 at noon ET on October 29, as investors welcomed improving customer traffic. The report also cites increasing labor costs.
M impact | EQUITY | Oct 29, 2026, 05:41 PM UTC
Linde Raises Full-Year Earnings Outlook as Shares Fall 1.43%
Linde lifted its full-year earnings forecast as electronics demand strengthened. Shares fell 1.43% to $500.88 at 11:54 a.m. ET on October 29.
M impact | EQUITY | Oct 29, 2026, 05:41 PM UTC